Long-term pantoprazole trial in patients with symptoms of chronic acid peptic complaints.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastric disorders; Gastro-oesophageal reflux; Peptic ulcer
- Focus Adverse reactions
- Sponsors Altana Group; Takeda Pharmaceuticals International GmbH
- 22 Oct 2012 Results were published in Alimentary Pharmacology and Therapeutics in April 2012, and were reported briefly in a Takeda Pharmaceuticals media release.
- 04 May 2012 Additional company (Takeda Global Research and Development Center) added in association as reported by ClinicalTrials.gov.
- 08 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.